Sartorius Stedim Biotech S.A. (EPA: DIM)
France
· Delayed Price · Currency is EUR 184.00
+0.30 (0.16%)
Aug 30, 2024, 5:35 PM CET
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 22.14B EUR in the quarter ending June 30, 2024, with 9.63% growth. This brings the company's revenue in the last twelve months to 44.74B, down -1.56% year-over-year. In the year 2023, Sartorius Stedim Biotech had annual revenue of 45.35B with 5.75% growth.
Revenue (ttm)
44.74B
Revenue Growth
-1.56%
P/S Ratio
6.31
Revenue / Employee
264.58K
Employees
10,382
Market Cap
17.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 45.35B | 2.47B | 5.75% |
| Dec 31, 2022 | 42.89B | 14.38B | 50.43% |
| Dec 31, 2021 | 28.51B | 2.50B | 9.60% |
| Dec 31, 2020 | 26.01B | -1.18B | -4.34% |
| Dec 31, 2019 | 27.19B | 1.24B | 4.77% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSartorius Stedim Biotech News
- 8 months ago - 10 stocks for investors looking for ‘wonderful companies at a fair price' - Market Watch
- 1 year ago - Sartorius, Sartorius Stedim shares fall after Polyplus acquisition - Market Watch